ArticleBMJ open2021

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial.

Visalini Nair-Shalliker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.